ClinicalTrials.gg
Sign In

Drug

Meropenem and vaborbactam clinical trials

studies test it
8
open now
2
in phase 3
4
first study started
2014

Keep track of what changes. Save the meropenem and vaborbactam studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Meropenem-Vaborbactam
6
Vabomere
5
Combination meropenem and vaborbactam
2
beta-lactamase inhibitor and carbapenem antibiotic
2
Carbavance
2

Studies by the year they started

8 studies that test it; most in 2014 (2)

Studies that test meropenem and vaborbactam, by start year
YearStudies
20142
20161
20182
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
1
Phase 3
4
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it.

Infections
2
Bacterial Infections
1
Urinary Tract Infections
1
Pneumonia
1

Who runs them

Industry 6 · Other 2

Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) (2) · Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) (2) · Melinta Therapeutics, Inc. (2) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · National University of Singapore (1)

Often tested with

Tested in the same studies.

Avibactam, ceftazidime drug combination (2) · Cefiderocol (2) · Aztreonam (2) · Eravacycline (2) · Tigecycline (2) · Imipenem (1) · Relebactam (1) · Aztreonam, avibactam drug combination (1)

Studies

Open first, then newest update. How each study uses meropenem and vaborbactam is read from its arms, and is right about nine times in ten.

Testing it · 8